NCT01771991View on ClinicalTrials.gov

Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Radiation Induced Fibrosis to the Head and Neck
Interventions
DRUG

Topical Sodermix Dismutase in the form of Sodermix (SOD)

Topical Sodermix Dismutase in the form of Sodermix (SOD) will be applied twice daily, of half dollar application for 12 weeks to fibrosed area.

DRUG

Placebo

Placebo or cetaphil cream will be applied twice daily, of half dollar size for 12 weeks to fibrosed area.

Trial Locations (1)

57105

Sanford Health, Sioux Falls

All Listed Sponsors
lead

Sanford Health

OTHER

NCT01771991 - Study of Topical Superoxide Dismutase to Treat Radiation Induced Fibrosis | Biotech Hunter | Biotech Hunter